Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ASC Speck veterinary vaccine
- Development stage
- Preclinical
- Lead developer
- Vaccizone
- Modality
- Recombinant Proteins and Enzymes, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular, Subcutaneous
01
Overview
The ASC Speck veterinary vaccine is a preclinical protein subunit vaccine candidate developed by Vaccizone using its proprietary ASC speck technology. This platform utilizes the Apoptosis-associated speck-like protein containing a CARD (ASC), which naturally assembles into large, stable macromolecular complexes known as "specks." By fusing veterinary antigens to these ASC specks, the vaccine creates a highly immunogenic particulate delivery system. The ASC specks function as an intrinsic adjuvant by activating the inflammasome and providing a potent "danger signal" to the innate immune system, thereby enhancing the adaptive immune response (both T-cell and B-cell) against the target pathogen. While the specific veterinary indication has not been disclosed, the platform is designed to improve vaccine efficacy and stability for animal health.
- Other names
- ASC Speck vaccineVaccizone veterinary vaccine
02
Targets
PYCARD (Apoptosis-associated speck-like protein containing a CARD)
Beyond the preview
Go deeper on ASC Speck veterinary vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ASC Speck veterinary vaccine.